Study Finds Post‑Menopausal Ovaries May Promote Inflammation in Mice

New research challenges the long‑standing view that ovaries become biologically inactive after menopause. A study conducted on mouse models, published this week in *Nature Communications*, demonstrates that post‑menopausal ovaries undergo structural and molecular changes that enable them to function as a distinct inflammatory organ. The investigators, led by Dr. Elena Martínez at the University of Cambridge, observed that ovaries from aged, reproductively senescent mice exhibited increased expression of cytokines such as IL‑6 and TNF‑α, as well as a proliferation of immune‑cell infiltrates, compared with ovaries from younger counterparts. Histological analysis revealed a shift from follicular tissue to fibrotic stroma populated by macrophages and lymphocytes, suggesting a reprogramming of ovarian tissue toward immune activity rather than hormone production.

The findings provide a mechanistic basis for epidemiological links between menopause and heightened systemic inflammation, and they raise the possibility that residual ovarian tissue may contribute to age‑related inflammatory disorders in humans. While the mouse data cannot be directly extrapolated to clinical practice, the authors propose that targeting ovarian‑derived inflammatory pathways could represent a novel therapeutic avenue for managing post‑menopausal health risks. Further studies are planned to assess whether similar ovarian remodeling occurs in women and to explore its relevance to conditions such as cardiovascular disease and osteoporosis.